TAILLE DU FICHIER: 6,47 MB
DATE DE PUBLICATION: 2020-May-12
AUTEUR: Monique Sarret
NOM DE FICHIER: LOW MOLECULAR WEIGHT HEPARIN THERAPY.pdf
Heparin and its low-molecular-weight derivatives (e.g., enoxaparin, dalteparin, tinzaparin) ... The hyperkalemia can appear within a few days after the onset of heparin therapy. More rarely, the side-effects alopecia and osteoporosis can occur with chronic use. As with many drugs, overdoses of heparin can be fatal. In September 2006, heparin received worldwide publicity when three prematurely ...
Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.. Heparin is a naturally occurring polysaccharide that inhibits coagulation, the process that leads to thrombosis.